TRANQUIS THERAPEUTICS
Tranquis Therapeutics is discovering and developing innovative medicines with the potential to revolutionize the management of neurodegenerative and aging-related diseases and to dramatically reduce the burden these illnesses place on patients, families and societies worldwide. Founded on groundbreaking neuro-immunology research from the laboratory of Professor Edgar Engleman, MD, at Stanford University, Tranquis’ novel therapeutic approach targets underlying myeloid immune cell dysfunction th... at has been linked to a variety of nervous system disorders. The company’s portfolio is comprised of small molecules which cross the blood-brain barrier, and the lead therapeutic candidate has demonstrated highly encouraging effects in challenging preclinical models of Amyotrophic Lateral Sclerosis (ALS), Frontotemporal Dementia (FTD), Parkinson’s Disease (PD), and age-related cognitive impairment. Tranquis plans to initiate development in orphan neurodegenerative diseases such as ALS and FTD and later expand into more prevalent diseases such as PD and Alzheimer’s Disease.
TRANQUIS THERAPEUTICS
Industry:
Biotechnology Life Science
Founded:
2016-01-01
Address:
San Mateo, California, United States
Country:
United States
Website Url:
http://www.tranquis.com
Total Employee:
11+
Status:
Active
Contact:
(650) 684-8950
Email Addresses:
[email protected]
Total Funding:
30 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving SPF Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Analytics Content Delivery Network LetsEncrypt
Similar Organizations
Atalanta Therapeutics
Atalanta Therapeutics is a biotechnology company pioneering new treatment options for neurodegenerative diseases.
Idenix Pharmaceuticals
Idenix Pharmaceuticals is focused on the discovery and development of drugs for the treatment of human viral diseases.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Correlation Ventures
Correlation Ventures investment in Series A - Tranquis Therapeutics
Vivo Capital
Vivo Capital investment in Series A - Tranquis Therapeutics
Remiges Ventures
Remiges Ventures investment in Series A - Tranquis Therapeutics
SR One
SR One investment in Series A - Tranquis Therapeutics
Hillsborough Venture
Hillsborough Venture investment in Series A - Tranquis Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2021-12-01 | Tranquis Therapeutics Strengthens Leadership Team with Additions of Janet Hurt, MPH, as SVP of Clinical Evidence Generation and Faisal Shawwa, MBA, as SVP of Finance |
Official Site Inspections
http://www.tranquis.com Semrush global rank: 7.12 M Semrush visits lastest month: 890
- Host name: 210.252.154.104.bc.googleusercontent.com
- IP address: 104.154.252.210
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Tranquis Therapeutics"
Tranquis Therapeutics, Inc. | LinkedIn
Tranquis Therapeutics is a breakthrough biopharmaceutical company focused on developing a portfolio of promising small molecule drugs with a unique mechanism of action, capable of reprogramming ...See details»
Tranquis Therapeutics - Crunchbase Company Profile …
Organization. Tranquis Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ...See details»
Maintenance mode - Tranquis
This website is currently undergoing maintenance.See details»
Tranquis Therapeutics - Contacts, Employees, Board Members
Organization. Tranquis Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. ... Tranquis Therapeutics has 7 …See details»
Tranquis Therapeutics 2025 Company Profile: …
Tranquis Therapeutics is headquartered in Palo Alto, CA. What is the size of Tranquis Therapeutics? Tranquis Therapeutics has 12 total employees. What …See details»
Tranquis Therapeutics - VentureRadar
"Founded on groundbreaking immuno-neurology research by Tranquis’ scientific founder, Dr. Edgar Engleman, and his team at Stanford, we are discovering and developing a novel …See details»
TRANQUIS THERAPEUTICS, INC. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for TRANQUIS THERAPEUTICS, INC. of Palo Alto, CA. Get the latest business insights from Dun & Bradstreet.See details»
Tranquis Therapeutics - Org Chart, Teams, Culture & Jobs - The Org
Tranquis Therapeutics is discovering and developing innovative medicines with the potential to revolutionize the management of neurodegenerative and aging-related diseases and to …See details»
Tranquis Therapeutics - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Jul 9, 2020: Series A - …See details»
Tranquis Therapeutics - Remiges Ventures
May 20, 2019 Tranquis Therapeutics is a San Mateo, California based private company discovering and developing novel therapeutics focused on neurodegenerative diseases. The …See details»
Tranquis Therapeutics, Inc. (Tranquis Therapeutics, Inc.) …
June 21, 2022 12:00 UTC -Tranquis plans to start a Phase 2 trial in people living with ALS by the end of 2022- REDWOOD CITY, Calif.--(BUSINESS WIRE)-- Tranquis Therapeutics, Inc., a clinical stage immuno-neurology company …See details»
Tranquis
About Tranquis Therapeutics: Tranquis Therapeutics is a clinical stage biotech company based in the SF Bay Area. Tranquis discovers and develops innovative medicines with the potential to …See details»
Tranquis
Tranquis Therapeutics Strengthens Leadership Team with Appointments of Frederic Godderis as Chief Operating Officer and Jonas Hannestad, MD, PhD, as Chief Medical Officer - Expansion …See details»
Tranquis Therapeutics, Inc. – Life Sciences Directory
Tranquis Therapeutics, Inc. Revolutionizing the treatment of neurodegenerative and aging-related diseases. Add Review . Share. Save Tranquis Therapeutics, Inc. ...See details»
Tranquis Therapeutics - Craft
Tranquis Therapeutics is a company that develops a technology intended to remove brain myeloid cells associated with the disease. Its technology helps in altering a variety of brain cell-related …See details»
Tranquis Therapeutics Announces Successful Completion of Phase …
Tranquis plans to start a Phase 2 trial in ALS by the end of 2022 ... Source: Tranquis.com European organization for Professionals and Patients with ALS (EUpALS) ivzw Registered …See details»
What is Tranquis Therapeutics? Company Culture, Mission, Values
See what employees say it's like to work at Tranquis Therapeutics. Salaries, reviews, and more - all posted by employees working at Tranquis Therapeutics.See details»
Tranquis Therapeutics Launches with $30 Million Series A Funding …
Tranquis plans to initiate development in orphan neurodegenerative diseases such as ALS and FTD and later expand into more prevalent diseases such as PD and Alzheimer’s Disease. For …See details»
Tranquis
Tranquis Therapeutics Granted FDA Orphan Drug Designation for TQS-168 for the Treatment of Amyotrophic Lateral Sclerosis -Tranquis plans to start a Phase 2 trial in people living with ALS …See details»
Tranquis debuts with $30M for immune cell approach to …
Jul 9, 2020 Tranquis plans to move TQS-168 into the clinic in 2021. It is starting with smaller disease populations such as ALS and FTD before developing other compounds that target the …See details»